C-reactive protein...C-reactive
protein: It’s back (From the Editor). Clough JD. Jun 475
C-reactive protein: A ‘golden marker’
for inflammation and coronary artery disease. Patel VB, Robbins MA,
Topol EJ. Jun 521
C-reactive protein elevation can be
caused by conditions other than inflammation and may reflect biologic
aging (Commentary). Kushner I. Jun 535
Evidence of smoke and atherosclerotic
fire (Editorial). Mandell BF. Jun 538
Cancer...Addressing
both sides of a difficult controversy (From the Editor). Clough JD. Jan
8
Spiral CT for lung cancer screening: Is
it ready for prime time? Jain P, Arroliga AC. Jan 74
Preventive medicine and screening
(Letter). Galus M. Jan 82
Preventive medicine and screening (In
Reply). Goldberg TH. Jan 83
Low-dose spiral CT for lung cancer
screening (Letter). Meziane M, Decamp M. Jan 84
Should we offer semen cryopreservation to
men with testicular cancer? (1-Minute Consult). Pasqualotto FF, Agarwal
A. Feb 101
Managing menopause after breast cancer:
Balancing risks and benefits. Moore HCF. Mar 243
Cardiomyopathy...The
MUSTT Trial. Preventing sudden death in coronary cardiomyopathy:
Implantable defibrillators lead the way. Pavia S, Wilkoff BL. Feb 113
Cataract surgery...What
is the risk of complications from cataract surgery in patients taking
anticoagulants? (1-Minute Consult). Langston RHS. Feb 97
Central venous catheters...When
should central venous catheters be changed in the intensive care unit?
Should there be a rigid time based protocol for doing so? (1-Minute
Consult). Mette SA. Dec 994
Chlamydia pneumoniae...Is
atherosclerosis an infectious disease? Mawhorter SD, Lauer MA. May 449
Cholesterol...Making
the most of cholesterol-lowering margarines. Avery JK. Mar 194
Aggressive treatment of dyslipidemia: A
review of supporting evidence. Stein EA. Feb 130
New cholesterol guidelines: Better, but
harder to follow (From the Editor). Mandell BF. Jul 579
Using the new cholesterol guidelines in
everyday practice. Sprecher DM, Frolkis JP. Jul 617
Cholesterol: What you need to know
(Patient Information). Anonymous. Jul 623
Cholinesterase inhibitors...Use
of cholinesterase inhibitors for treatment of Alzheimer disease (Medical
Grand Rounds). Hake AM. Jul 608
Chronic myelogenous leukemia...Chronic
myelogenous leukemia: The news you have and haven’t heard (Medical
Grand Rounds). Kalaycio ME. Nov 913
Chronic obstructive pulmonary disease...Does
salmeterol increase mortality in patients with COPD? (1-Minute Consult).
Gerber RB, Kavuru M. Jul 600
Computed tomography...Addressing
both sides of a difficult controversy (From the Editor). Clough JD. Jan
8
Spiral CT for lung cancer screening: Is
it ready for prime time? Jain P, Arroliga AC. Jan 74
Preventive medicine and screening
(Letter). Galus M. Jan 82
Preventive medicine and screening (In
Reply). Goldberg TH. Jan 83
Low-dose spiral CT for lung cancer
screening (Letter). Meziane M, Decamp M. Jan 84
Computers...Finding
evidence-based answers to clinical questions online (Medical Grand
Rounds). Mehta N, Jain A. Apr 307
Handheld computers are fun, sometimes
even useful (From the Editor). Clough JD. Oct 819
Information at hand: Using handheld
computers in medicine. Embi PJ. Oct 840
Handheld computers in medicine: The
future is not here yet (Editorial). Harris CM. Oct 854
Coronary artery disease...Should
patients with documented or probable coronary artery disease routinely
be placed on beta-blockers before noncardiac surgery? (1-Minute
Consult). Isaacson JH. Apr 273UAL
INDEX 2001
Safe use of sildenafil in patients with
coronary artery disease. Bush HS. Apr 349
Coronary artery disease in women:
Different, often undertreated. Jneid H, Thacker HL. May 441
Is atherosclerosis an infectious disease?
Mawhorter SD, Lauer MA. May 449
C-reactive protein: A ‘golden marker’
for inflammation and coronary artery disease. Patel VB, Robbins MA,
Topol EJ. Jun 521
C-reactive protein elevation can be
caused by conditions other than inflammation and may reflect biologic
aging (Commentary). Kushner I. Jun 535
Evidence of smoke and atherosclerotic
fire (Editorial). Mandell BF. Jun 538
In-stent restenosis: Update on
intracoronary radiotherapy. Chan AW, Moliterno DJ. Sep 796
A 62-year-old man with an abnormal
electrocardiogram (The Clinical Picture). Rimmerman CM. Dec 975
GP IIb/IIIa inhibitors in coronary artery
disease management: What the latest trials tell us. Chew DP, Moliterno
DJ. Dec 1017
Cyclo-oxygenase 2 inhibitors...COX-2
inhibitors: Balancing the hope, the hype, and the concern (From the
Editor). Mandell BF. Nov 899
COX-2 inhibitors and cardiovascular risk:
Point and counterpoint (Editorial). Mandell BF. Nov 957
COX-2 inhibitors and cardiovascular risk:
The data are inconclusive and these drugs are needed (Point and
Counterpoint). Lipani J. Nov 961
COX-2 inhibitors and cardiovascular risk:
We defend our data and suggest caution. Mukherjee D, Nissen SE, Topol EJ.
Nov 963
